Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...
Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...
Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...
Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...
Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
